Carolyn K McCourt MD
Gynecologic Oncology
Assistant Professor, Obstetrics and Gynecology, Brown University Program in Medicine
Join to View Full Profile
4921 Parkview Pl# DvSaint Louis, MO 63110
Phone+1 314-362-3181
Fax+1 314-362-2893
Dr. McCourt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Obstetrics and Gynecology, 2001 - 2005
Creighton University School of MedicineClass of 2001
Certifications & Licensure
IL State Medical License 2020 - 2026
MO State Medical License 2014 - 2026
RI State Medical License 2005 - 2016
CT State Medical License 2008 - 2014
MA State Medical License 2008 - 2014
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
- Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer Start of enrollment: 2010 Sep 07
- Panitumumab and Gemcitabine in Relapsed Ovarian Cancer Start of enrollment: 2011 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Society of Family Planning Committee Statement: Contraceptive considerations for individuals with cancer and cancer survivors part 1 - Key considerations for clinical ...Pelin Batur, Ashley Brant, Carolyn McCourt, Eleanor Bimla Schwarz,
Contraception. 2025-03-27 - Society of Family Planning Clinical Recommendation: Contraceptive considerations for individuals with cancer and cancer survivors part 2 - Breast, ovarian, uterine, an...Pelin Batur, Ashley Brant, Carolyn McCourt, Eleanor Bimla Schwarz,
Contraception. 2025-03-27 - Comprehensive Molecular and Genomic Analysis of NCI-MATCH Subprotocol Y: Capivasertib in Patients With an-Mutated Tumor.Carolyn K McCourt, Jacob Gross, Kevin Kalinsky, Ping Guan, Lisa M McShane
JCO Precision Oncology. 2025-03-01
Journal Articles
- Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian CancerIan S Hagemann, Premal H Thaker, Carolyn K McCourt, Katherine C Fuh, David G Mutch, Andrea R Hagemann, Matthew A Powell, Clinical Cancer Research
- Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous CancerIan S Hagemann, Carolyn K McCourt, Matthew A Powell, Premal H Thaker, David G Mutch, Katherine C Fuh, Andrea R Hagemann, Clinical Cancer Research
Press Mentions
NCI-MATCH Cancer Trial Finds a Promising Signal for the AKT Inhibitor IpatasertibOctober 26th, 2022
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
